Limited evidence for the role of environmental factors in the unusual peak of influenza in Brisbane during the 2018-2019 Australian summer.

Distributed lag nonlinear models Environmental factors Influenza virus Intraseasonal influenza

Journal

The Science of the total environment
ISSN: 1879-1026
Titre abrégé: Sci Total Environ
Pays: Netherlands
ID NLM: 0330500

Informations de publication

Date de publication:
01 Jul 2021
Historique:
received: 17 11 2020
revised: 31 01 2021
accepted: 13 02 2021
pubmed: 1 3 2021
medline: 30 4 2021
entrez: 28 2 2021
Statut: ppublish

Résumé

To explore the contribution of environmental factors in the unusual pattern of influenza activity observed in Brisbane, Australia during the summer of 2018-2019. Distributed lag nonlinear models (DLNMs) were used to estimate the effect of environmental factors on weekly influenza incidence in Brisbane. Next generation sequencing was then employed to analyze minor and majority variants in influenza strains isolated from Brisbane children during this period. There were limited marked differences in the environmental factors observed in Brisbane between the 2018-2019 summer period and the same period of the proceeding years, with the exception of significant reduction in rainfall. DLNM showed that reduced rainfall in Brisbane (at levels consistent with the 2018-2019 period) correlated with a dramatic increase in the relative risk of influenza. Sulfur dioxide (SO Taken together, these data suggest a limited role for key environmental factors in the influenza activity observed in Brisbane, Australia during the summer of 2018-2019. One alternative explanation may that viral factors, in addition to other factors not studied herein, contributed to the unusual influenza season. Our findings provide fundamental information that may be beneficial to a better understanding of the seasonal trends of influenza virus.

Identifiants

pubmed: 33640553
pii: S0048-9697(21)01034-2
doi: 10.1016/j.scitotenv.2021.145967
pii:
doi:

Substances chimiques

Sulfur Dioxide 0UZA3422Q4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

145967

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: KRS provides educational seminars for Roche and Novo Nordisk.

Auteurs

Jianyun Lu (J)

Guangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong Province 510440, China; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072, Australia.

Zhicong Yang (Z)

Guangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong Province 510440, China.

Anjana C Karawita (AC)

School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072, Australia.

Myrna Bunte (M)

School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072, Australia.

Keng Yih Chew (KY)

School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072, Australia.

Cassandra Pegg (C)

School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072, Australia.

Ian Mackay (I)

Public Health Virology Laboratory, Forensic and Scientific Services, Coopers Plains, Queensland, Australia; Child Health Research Centre, The University of Queensland, Brisbane, Queensland, Australia.

David Whiley (D)

The University of Queensland Centre for Clinical Research, Australia and Pathology Queensland Central Laboratory, Brisbane, Queensland, Australia.

Kirsty R Short (KR)

School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072, Australia; Australian Infectious Diseases Research Centre, The University of Queensland, St Lucia, QLD 4072, Australia. Electronic address: k.short@uq.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH